Swiss Re AG/€SREN
1D1W1MYTD1Y5YMAX
Capital at risk
About Swiss Re AG
Swiss Re AG is a global reinsurance company based in Zurich, Switzerland. It operates primarily in the reinsurance industry, offering both traditional reinsurance products and insurance-based capital market solutions. The company’s core segments include Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions, which provides commercial insurance tailored for large and midsize corporations. Founded in 1863, Swiss Re has built a long-standing reputation for absorbing complex risks globally. It maintains a diverse geographic footprint, serving customers and clients across the Americas, Europe, Asia Pacific, and other regions. Swiss Re's strategic positioning is supported by its strong capital base, extensive risk knowledge, and a commitment to developing innovative risk management solutions.
- Ticker
- €SREN
- Sector
- Finance
- Primary listing
- XGAT
- Employees
- 14,522
- Headquarters
- Zurich, Switzerland
- Website
- www.swissre.com
Swiss Re AG Metrics
BasicAdvanced
€44B
10.42
€14.22
0.35
€6.83
4.61%
Price and volume
Market cap
€44B
Beta
0.35
52-week high
€166.95
52-week low
€124.20
Average daily volume
705K
Dividend rate
€6.83
Financial strength
Current ratio
3.001
Quick ratio
1.898
Long term debt to equity
0.348
Total debt to equity
0.378
Dividend payout ratio (TTM)
47.38%
Interest coverage (TTM)
15.41%
Profitability
EBITDA (TTM)
5,929.663
Gross margin (TTM)
20.56%
Net profit margin (TTM)
11.89%
Operating margin (TTM)
16.20%
Effective tax rate (TTM)
23.68%
Revenue per employee (TTM)
€2,494,510
Management effectiveness
Return on assets (TTM)
3.16%
Return on equity (TTM)
20.36%
Valuation
Price to earnings (TTM)
10.417
Price to revenue (TTM)
1.196
Price to book
1.68
Price to tangible book (TTM)
2.01
Price to free cash flow (TTM)
20.692
Free cash flow yield (TTM)
4.83%
Free cash flow per share (TTM)
7.16
Dividend yield (TTM)
4.61%
Forward dividend yield
4.61%
Growth
Revenue change (TTM)
-4.61%
Earnings per share change (TTM)
30.64%
3-year revenue growth (CAGR)
-1.89%
10-year revenue growth (CAGR)
0.72%
3-year earnings per share growth (CAGR)
34.09%
10-year earnings per share growth (CAGR)
3.71%
3-year dividend per share growth (CAGR)
7.72%
10-year dividend per share growth (CAGR)
5.70%
Bulls say / Bears say
Swiss Re’s net income rose 9% to USD 2.8 billion in the first half of 2026, putting the company on track to meet its full-year targets amid disciplined underwriting and low large-loss experience (Reuters)
The Group’s Swiss Solvency Test ratio stood at 264% as of 1 July 2026, above its 200–250% target range, reinforcing Swiss Re’s strong capital base and capacity for growth and shareholder return (FT)
The Board approved a share repurchase program of up to USD 1.5 billion in 2026, demonstrating management’s confidence in Swiss Re’s valuation and commitment to returning capital to shareholders (Swissinfo.ch)
Insurance revenue in Q1 2026 fell 4% year-on-year to USD 4.1 billion, highlighting top-line pressure in a competitive renewal environment (Reuters)
Swiss Re’s Life & Health Reinsurance unit recorded a USD 650 million assumption-update charge in 2025, missing its internal net income target and underscoring residual underwriting volatility in legacy portfolios (Investing.com)
S&P Global Ratings reported that leading reinsurers, including Swiss Re, faced risk-adjusted price reductions of 3–5% across their portfolios during 2026 renewals, signalling intensifying competition and margin compression (S&P Global Ratings)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.